Page last updated: 2024-08-17

spironolactone and leptin

spironolactone has been researched along with leptin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Haluzík, M; Prázný, M; Sindelka, G; Skrha, J; Widimský, J; Zelinka, T1
Fukami, T; Gomori, A; Ishihara, A; Ito, J; Iwaasa, H; Kanatani, A; Kitazawa, H; MacNeil, DJ; Mashiko, S; Matsushita, H; Mitobe, Y; Moriya, R; Takahashi, T; Van der Ploeg, LH1
Bhat, GA; Ganie, MA; Rashid, A; Shah, ZA; Shaheen, F; Shrivastava, M; Wani, IA1

Trials

1 trial(s) available for spironolactone and leptin

ArticleYear
Differential Impact of Insulin Sensitizers vs. Anti-Androgen on Serum Leptin Levels in Vitamin D Replete PCOS Women: A Six Month Open Labeled Randomized Study.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2020, Volume: 52, Issue:2

    Topics: Adult; Blood Glucose; Female; Humans; Insulin; Insulin Resistance; Leptin; Metformin; Pioglitazone; Polycystic Ovary Syndrome; Spironolactone; Testosterone; Vitamin D; Young Adult

2020

Other Studies

2 other study(ies) available for spironolactone and leptin

ArticleYear
Serum leptin levels in patients with primary hyperaldosteronism before and after treatment: relationships to insulin sensitivity.
    Journal of human hypertension, 2002, Volume: 16, Issue:1

    Topics: Adrenal Glands; Adrenalectomy; Adult; Female; Glucose Clamp Technique; Humans; Hyperaldosteronism; Hyperinsulinism; Insulin; Insulin Resistance; Insulin Secretion; Leptin; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Spironolactone

2002
Effects of a novel Y5 antagonist in obese mice: combination with food restriction or sibutramine.
    Obesity (Silver Spring, Md.), 2008, Volume: 16, Issue:7

    Topics: Adiposity; Animals; Anti-Obesity Agents; Appetite Depressants; Blood Glucose; Body Weight; Caloric Restriction; Combined Modality Therapy; Cyclobutanes; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Eating; Insulin; Leptin; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Obesity; Receptors, Neuropeptide Y; Spiro Compounds; Spironolactone; Time Factors

2008